{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:19:34Z","timestamp":1788808774114,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37AI048793"],"award-info":[{"award-number":["R37AI048793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014535","name":"Mayo Clinic Center for Individualized Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014535","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.049","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T14:55:47Z","timestamp":1558450547000},"page":"3876-3882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Seroprevalence and durability of rubella virus antibodies in a highly immunized population"],"prefix":"10.1016","volume":"37","author":[{"given":"Stephen N.","family":"Crooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iana H.","family":"Haralambieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-4457","authenticated-orcid":false,"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"271","key":"10.1016\/j.vaccine.2019.05.049_b0005","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJM196412172712501","article-title":"Virologic and serologic studies on human products of conception after maternal rubella","volume":"17","author":"Alford","year":"1964","journal-title":"N Engl J Med"},{"issue":"8302","key":"10.1016\/j.vaccine.2019.05.049_b0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(82)92677-0","article-title":"Consequences of confirmed maternal rubella at successive stages of pregnancy","volume":"2","author":"Miller","year":"1982","journal-title":"Lancet"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2019.05.049_b0015","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0264-410X(01)00073-1","article-title":"Rubella eradication","volume":"19","author":"Plotkin","year":"2001","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2019.05.049_b0020","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.vaccine.2014.03.097","article-title":"Healthcare providers as sources of vaccine-preventable diseases","volume":"32","author":"Sydnor","year":"2014","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2019.05.049_b0025","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1016\/j.vaccine.2012.08.057","article-title":"Measles, mumps, and rubella virus vaccine (M-M-RII): a review of 32 years of clinical and postmarketing experience","volume":"30","author":"Lievano","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.049_b0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S1020-49892003001000005","article-title":"Rubella and congenital rubella syndrome: global update","volume":"14","author":"Robertson","year":"2003","journal-title":"Rev Panam Salud Publica"},{"issue":"20","key":"10.1016\/j.vaccine.2019.05.049_b0035","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","article-title":"Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad((R))) in infants from 9 months of age","volume":"30","author":"Vesikari","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.049_b0040","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.049_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-013-8475-y","article-title":"Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts","volume":"58","author":"Lambert","year":"2013","journal-title":"Immunol Res"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.049_b0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/CVI.00681-13","article-title":"High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers","volume":"21","author":"Lambert","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.049_b0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/infdis\/jix538","article-title":"Polymorphisms in the wilms tumor gene are associated with interindividual variations in rubella virus-specific cellular immunity after measles-mumps-rubella II vaccination","volume":"217","author":"Voigt","year":"2018","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.05.049_b0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00251-015-0864-z","article-title":"Single nucleotide polymorphisms\/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children","volume":"67","author":"Ovsyannikova","year":"2015","journal-title":"Immunogenet"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.049_b0065","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiu553","article-title":"Polymorphisms in HLA-DPB1 are associated with differences in rubella-specific humoral immunity after vaccination","volume":"211","author":"Lambert","year":"2015","journal-title":"J Infect Dis"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2019.05.049_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00251-014-0776-3","article-title":"Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients","volume":"66","author":"Kennedy","year":"2014","journal-title":"Immunogenet"},{"issue":"33","key":"10.1016\/j.vaccine.2019.05.049_b0075","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1016\/j.vaccine.2014.04.091","article-title":"HLA genotypes and rubella vaccine immune response: additional evidence","volume":"32","author":"Ovsyannikova","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2019.05.049_b0080","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.21.20485-en","article-title":"Ongoing outbreak of rubella among young male adults in Poland: increased risk of congenital rubella infections","volume":"18","author":"Paradowska-Stankiewicz","year":"2013","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.049_b0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jinf.2013.09.002","article-title":"Causes of a nationwide rubella outbreak in Japan, 2012\u20132013","volume":"68","author":"Minakami","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2019.05.049_b0090","unstructured":"Minnesota Statutes 2018, section 121A.15, subdivision 1; Health standards; immunizations; school children. https:\/\/www.revisor.mn.gov\/statutes\/cite\/121A.15."},{"issue":"9","key":"10.1016\/j.vaccine.2019.05.049_b0095","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.mayocp.2013.06.006","article-title":"The Mayo Clinic Biobank: a building block for individualized medicine","volume":"88","author":"Olson","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.vaccine.2019.05.049_b0100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.049_b0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.vaccine.2012.11.014","article-title":"Waning immunity to measles in young adults and booster effects of revaccination in secondary school students","volume":"31","author":"He","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.049_b0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14760584.2018.1445529","article-title":"Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study","volume":"17","author":"Liu","year":"2018","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.05.049_b0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fphys.2017.00233","article-title":"Waning immunity is associated with periodic large outbreaks of mumps: a mathematical modeling study of Scottish data","volume":"8","author":"Hamami","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.049_b0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"36","key":"10.1016\/j.vaccine.2019.05.049_b0125","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2015.06.101","article-title":"The weight of obesity on the human immune response to vaccination","volume":"33","author":"Painter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.049_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41514-017-0020-0","article-title":"Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging","volume":"4","author":"Del Giudice","year":"2018","journal-title":"NPJ Aging Mech Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.05.049_b0135","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ijo.2011.208","article-title":"Obesity is associated with impaired immune response to influenza vaccination in humans","volume":"36","author":"Sheridan","year":"2012","journal-title":"Intl J Obesity"},{"issue":"16","key":"10.1016\/j.vaccine.2019.05.049_b0140","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.vaccine.2014.01.066","article-title":"Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage","volume":"32","author":"Smits","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.049_b0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jmv.23757","article-title":"Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women","volume":"86","author":"Barlinn","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2019.05.049_b0150","doi-asserted-by":"crossref","first-page":"659838","DOI":"10.1155\/2014\/659838","article-title":"Rubella Immunity among pregnant women in Jeddah, western region of Saudi Arabia","volume":"2014","author":"Alsibiani","year":"2014","journal-title":"Obstet Gynecol Int"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.049_b0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2011.11.045","article-title":"Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004-2009. Is rubella susceptibility increasing?","volume":"30","author":"Byrne","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.05.049_b0160","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/508826","article-title":"Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia","volume":"27","author":"Almuneef","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.049_b0165","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2019.05.049_b0170","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1016\/j.vaccine.2010.09.082","article-title":"Seroprevalence of rubella in female migrant factory workers in Shenzhen","volume":"28","author":"Mou","year":"2010","journal-title":"China. Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.049_b0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/1119-3077.84002","article-title":"Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria","volume":"14","author":"Onakewhor","year":"2011","journal-title":"Niger J Clin Pract"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.049_b0180","doi-asserted-by":"crossref","first-page":"e89361","DOI":"10.1371\/journal.pone.0089361","article-title":"Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2019.05.049_b0185","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/00006454-199409000-00013","article-title":"Congenital rubella after anticipated maternal immunity: two cases and a review of the literature","volume":"13","author":"Robinson","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.05.049_b0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0163-4453(97)94507-2","article-title":"Subclinical rubella reinfection during pregnancy followed by transmission of virus to the fetus","volume":"34","author":"Aboudy","year":"1997","journal-title":"J Infect"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.05.049_b0195","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1093\/infdis\/jir098","article-title":"Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission","volume":"204","author":"Rota","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.049_b0200","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/14760584.2017.1294069","article-title":"Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review","volume":"16","author":"Leung","year":"2017","journal-title":"Exp Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2019.05.049_b0205","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1517\/14712598.8.11.1659","article-title":"Personalized vaccines: the emerging field of vaccinomics","volume":"8","author":"Poland","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2019.05.049_b0210","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.ppat.1002344","article-title":"Vaccinomics and personalized vaccinology: Is science leading us toward a new path of directed vaccine development and discovery?","volume":"7","author":"Poland","year":"2011","journal-title":"PLoS Pathog"},{"issue":"23","key":"10.1016\/j.vaccine.2019.05.049_b0215","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.vaccine.2013.02.070","article-title":"Personalized vaccinology: one size and dose might not fit both sexes","volume":"31","author":"Klein","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.049_b0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14760584.2014.905744","article-title":"The personal touch: strategies toward personalized vaccines and predicting immune responses to them","volume":"13","author":"Kennedy","year":"2014","journal-title":"Exp Rev Vacc"},{"issue":"22","key":"10.1016\/j.vaccine.2019.05.049_b0225","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004\u20132005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2019.05.049_b0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/tropej\/40.2.104","article-title":"Female children respond to recombinant hepatitis B vaccine with a higher titre than male","volume":"40","author":"Fang","year":"1994","journal-title":"J Trop Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.049_b0235","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4161\/hv.27498","article-title":"Are healthcare workers immune to rubella?","volume":"10","author":"Borras","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2019.05.049_b0240","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1086\/505947","article-title":"Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?","volume":"43","author":"Hyde","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.049_b0245","doi-asserted-by":"crossref","first-page":"ofv006","DOI":"10.1093\/ofid\/ofv006","article-title":"Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010","volume":"2","author":"Lebo","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2019.05.049_b0250","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.vaccine.2009.01.086","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.05.049_b0255","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/00222615-48-12-1075","article-title":"Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation","volume":"48","author":"Mitchell","year":"1999","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.049_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: Implications for response to infection and vaccination in older people","author":"Pera","year":"2015","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.049_b0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.049_b0270","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.05.049_b0275","unstructured":"Minnesota Department of Health. Rubella disease statistics. http:\/\/www.health.state.mn.us\/divs\/idepc\/diseases\/rubella\/stats.html."},{"issue":"8","key":"10.1016\/j.vaccine.2019.05.049_b0280","doi-asserted-by":"crossref","first-page":"e0183630","DOI":"10.1371\/journal.pone.0183630","article-title":"Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger","volume":"12","author":"Hui","year":"2017","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.049_b0285","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cid\/civ440","article-title":"Immunity to measles, mumps, and rubella in US children with perinatal HIV infection or perinatal HIV Exposure without infection","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2019.05.049_b0290","first-page":"00574","article-title":"Poland GA. Lessons learned in the analysis of high-dimensional data in vaccinomics","volume":"S0264-410X","author":"Oberg","year":"2015","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2019.05.049_b0295","first-page":"1171","article-title":"Vaccination coverage among children aged 19\u201335 months - United States, 2016","volume":"66","author":"Hill","year":"2017","journal-title":"MMWR"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2020.09.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T10:23:10Z","timestamp":1663496590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":59,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X19306735"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.049","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.vaccine.2020.09.026","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence and durability of rubella virus antibodies in a highly immunized population","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}